3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
13
Leukemia, Myeloid, Acute
12
Myelodysplastic Syndromes
11
Hodgkin Disease
8
Lymphoma, Non-Hodgkin
7
Multiple Myeloma
6
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
6
Leukemia, Myelomonocytic, Chronic
5
Myeloproliferative Disorders
4
Lymphoma
4
Leukemia, Lymphocytic, Chronic, B-Cell
4
Leukemia
4
Burkitt Lymphoma
4
Anemia, Refractory, with Excess of Blasts
4
Recurrence
3
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Lymphoma, Mantle-Cell
3
Lymphoma, Large B-Cell, Diffuse
3
Lymphoma, Follicular
3
Leukemia, Myeloid, Accelerated Phase
3
Leukemia, Biphenotypic, Acute
3
Colorectal Neoplasms
3
Blastic Plasmacytoid Dendritic Cell Neoplasm
3
Stomach Neoplasms
2
Sarcoma
2
Primary Myelofibrosis
2
Pancreatic Neoplasms
2
Osteosarcoma
2
Neuroblastoma
2
Neoplasms, Plasma Cell
2
Interventions
dexamethasone acetate
2
dexamethasone 21-phosphate
2
auricularum
2
Specimen Handling
2
Magnetic Resonance Spectroscopy
2
Dexamethasone
2
Calcium Dobesilate
2
Biopsy
2
4-(N-methylamino)-4'-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)stilbene
2
venetoclax
1
ixazomib
1
daratumumab
1
belantamab mafodotin
1
X-Rays
1
Stem Cell Transplantation
1
Phantoms, Imaging
1
Melphalan
1
Cyclophosphamide
1
Bortezomib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Immunoglobulin Light-chain Amyloidosis
×
fludarabine phosphate
×
30 days
×
Clear all
No trials found.